H2 control of natural T regulatory cell frequency in the lymph node correlates with susceptibility to day 3 thymectomy-induced autoimmune disease

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 382-389

  Del Rio, Roxana ^a   Sun, Yuefang ^b   Alard, Pascale ^b,c   Tung, Kenneth S K ^b   Teuscher, Cory ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DACRYOADENITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE OVARIAN DYSGENESIS; CHROMOSOME 1; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME SUBSTITUTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GONADAL DYSGENESIS; H2 RESTRICTION; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; LACRIMAL GLAND DISEASE; LYMPH NODE; MOUSE; NONHUMAN; ORCHITIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; QUANTITATIVE TRAIT LOCUS MAPPING; REGULATORY T LYMPHOCYTE; THYMECTOMY;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMOSOMES; DACRYOCYSTITIS; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC LINKAGE; H-2 ANTIGENS; LYMPH NODES; LYMPHOCYTE COUNT; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, TRANSGENIC; OOPHORITIS; QUANTITATIVE TRAIT LOCI; T-LYMPHOCYTES, REGULATORY; THYMECTOMY;

EID: 79251543615     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002110     Document Type: Article

References (43)

1. Josefowicz, S. Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30: 616-625.
2. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
3. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
4. Bensinger, S. J., A. Bandeira, M. S. Jordan, A. J. Caton, and T. M. Laufer. 2001. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 194: 427-438.
5. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, and A. J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
6. Liston, A., K. M. Nutsch, A. G. Farr, J. M. Lund, J. P. Rasmussen, P. A. Koni, and A. Y. Rudensky. 2008. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 105: 11903-11908.
7. Ribot, J., G. Enault, S. Pilipenko, A. Huchenq, M. Calise, D. Hudrisier, P. Romagnoli, and J. P. van Meerwijk. 2007. Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection. J. Immunol. 179: 6741-6748.
8. Ferreira, C., Y. Singh, A. L. Furmanski, F. S. Wong, O. A. Garden, and J. Dyson. 2009. Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 8320-8325.
9. Joetham, A., K. Takeda, N. Miyahara, S. Matsubara, H. Ohnishi, T. Koya, A. Dakhama, and E. W. Gelfand. 2007. Activation of naturally occurring lung CD4(+)CD25(+) regulatory T cells requires CD8 and MHC I interaction. Proc. Natl. Acad. Sci. USA 104: 15057-15062.
10. Westendorf, A. M., D. Fleissner, L. Groebe, S. Jung, A. D. Gruber, W. Hansen, and J. Buer. 2009. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells. Gut 58: 211-219.
11. Mandik-Nayak, L., B. T. Wipke, F. F. Shih, E. R. Unanue, and P. M. Allen. 2002. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc. Natl. Acad. Sci. USA 99: 14368-14373.
12. Scheinecker, C., R. McHugh, E. M. Shevach, and R. N. Germain. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196: 1079-1090.
13. Tung, K. S., Y. Y. Setiady, E. T. Samy, J. Lewis, and C. Teuscher. 2005. Autoimmune ovarian disease in day 3-thymectomized mice: the neonatal time window, antigen specificity of disease suppression, and genetic control. Curr. Top. Microbiol. Immunol. 293: 209-247.
14. Carson, W. F., IV, L. A. Guernsey, A. Singh, A. T. Vella, C. M. Schramm, and R. S. Thrall. 2008. Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model. Int. Arch. Allergy Immunol. 145: 231-243.
15. Jaeckel, E., H. von Boehmer, and M. P. Manns. 2005. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54: 306-310.
16. Samy, E. T., L. A. Parker, C. P. Sharp, and K. S. Tung. 2005. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J. Exp. Med. 202: 771-781.
17. Tritt, M., E. Sgouroudis, E. d'Hennezel, A. Albanese, and C. A. Piccirillo. 2008. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57: 113-123.
18. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39: 329-337.
19. Zhang, N., B. Schröppel, G. Lal, C. Jakubzick, X. Mao, D. Chen, N. Yin, R. Jessberger, J. C. Ochando, Y. Ding, and J. S. Bromberg. 2009. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30: 458-469.
20. Kojima, A., and R. T. Prehn. 1981. Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14: 15-27.
21. Nishizuka, Y., and T. Sakakura. 1971. Ovarian dysgenesis induced by neonatal thymectomy in the mouse. Endocrinology 89: 886-893.
22. Roper, R. J., R. Z. Ma, J. E. Biggins, R. J. Butterfield, S. D. Michael, K. S. Tung, R. W. Doerge, and C. Teuscher. 2002. Interacting quantitative trait loci control loss of peripheral tolerance and susceptibility to autoimmune ovarian dysgenesis after day 3 thymectomy in mice. J. Immunol. 169: 1640-1646.
23. Wardell, B. B., S. D. Michael, K. S. Tung, J. A. Todd, E. P. Blankenhorn, K. McEntee, J. D. Sudweeks, W. K. Hansen, N. D. Meeker, J. S. Griffith, et al. 1995. Aod1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16. Proc. Natl. Acad. Sci. USA 92: 4758-4762.
24. Singer, J. B., A. E. Hill, L. C. Burrage, K. R. Olszens, J. Song, M. Justice, W. E. O'Brien, D. V. Conti, J. S. Witte, E. S. Lander, and J. H. Nadeau. 2004. Genetic dissection of complex traits with chromosome substitution strains of mice. Science 304: 445-448.
25. Avner, P. 1998. Complex traits and polygenic inheritance in the mouse. Methods 14: 191-198. (Pubitemid 28408135)
26. Alard, P., C. Thompson, S. S. Agersborg, J. Thatte, Y. Setiady, E. Samy, and K. S. Tung. 2001. Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy. J. Immunol. 166: 4363-4369.
27. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184: 387-396.
28. Smith, H., I. M. Chen, R. Kubo, and K. S. Tung. 1989. Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus. Science 245: 749-752.
29. Samy, E. T., K. M. Wheeler, R. J. Roper, C. Teuscher, and K. S. Tung. 2008. Cutting edge: Autoimmune disease in day 3 thymectomized mice is actively controlled by endogenous disease-specific regulatory T cells. J. Immunol. 180: 4366-4370.
30. Feuerer, M., W. Jiang, P. D. Holler, A. Satpathy, C. Campbell, M. Bogue, D. Mathis, and C. Benoist. 2007. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 104: 18181-18186.
31. Romagnoli, P., J. Tellier, and J. P. van Meerwijk. 2005. Genetic control of thymic development of CD4+CD25+FoxP3+ regulatory T lymphocytes. Eur. J. Immunol. 35: 3525-3532.
32. Tellier, J., J. P. van Meerwijk, and P. Romagnoli. 2006. An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes. Int. Immunol. 18: 1509-1519.
33. Butterfield, R. J., J. D. Sudweeks, E. P. Blankenhorn, R. Korngold, J. C. Marini, J. A. Todd, R. J. Roper, and C. Teuscher. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161: 1860-1867.
34. Roper, R. J., R. W. Doerge, S. B. Call, K. S. Tung, W. F. Hickey, and C. Teuscher. 1998. Autoimmune orchitis, epididymitis, and vasitis are immunogenetically distinct lesions. Am. J. Pathol. 152: 1337-1345.
35. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
36. Eastaff-Leung, N., N. Mabarrack, A. Barbour, A. Cummins, and S. Barry. 2010. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 30: 80-89.
37. Pop, S. M., C. P. Wong, D. A. Culton, S. H. Clarke, and R. Tisch. 2005. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J. Exp. Med. 201: 1333-1346.
38. Takahashi, M., K. Nakamura, K. Honda, Y. Kitamura, T. Mizutani, Y. Araki, T. Kabemura, Y. Chijiiwa, N. Harada, and H. Nawata. 2006. An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig. Dis. Sci. 51: 677-686.
39. Wheeler, K. M., E. T. Samy, and K. S. Tung. 2009. Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity. J. Immunol. 183: 7635-7638.
40. Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R. A. Sobel, K. W. Wucherpfennig, and V. K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101: 15434-15439.
41. Kodama, K., A. J. Butte, R. J. Creusot, L. Su, D. Sheng, M. Hartnett, H. Iwai, L. R. Soares, and C. G. Fathman. 2008. Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clin. Immunol. 129: 195-201.
42. Lathrop, S. K., N. A. Santacruz, D. Pham, J. Luo, and C. S. Hsieh. 2008. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205: 3105-3117.
43. Gagnerault, M. C., J. J. Luan, C. Lotton, and F. Lepault. 2002. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196: 369-377.